Stock Down Under

Money-Making Insights On

ASX-Listed Stocks

Recent Articles

Iron Ore Falls to $103 on China’s Near-Record Stockpiles- What It Means for ASX Mining Stocks

April 11, 2026

ASX Mining Stocks Under Pressure…

Life360 (ASX: 360) Cuts Jobs for AI- Red Flag or the Best Reason to Buy This ASX Tech Stock Right Now?

April 11, 2026

Life360’s AI move could be…

AMA Group (ASX:AMA) recovery is now being tested by whether cash flow can sustain the turnaround

April 10, 2026

AMA Group (ASX: AMA)’s recovery…

Radiopharm Theranostics (ASX: RAD) is increasingly defined by whether RAD101 can justify a registrational pathway

April 10, 2026

Radiopharm Theranostics (ASX:RAD) is increasingly…

3P Learning (ASX:3PL) must arrest school churn to protect its valuation

April 10, 2026

3P Learning (ASX: 3PL)’s valuation…

IperionX (ASX: IPX) needs repeat Virginia orders to unlock its titanium platform value

April 10, 2026

IperionX (ASX: IPX) is now…

Telix Pharmaceuticals (ASX:TLX) Big Upside, but Only if the FDA Says Yes.

April 10, 2026

Telix Pharmaceuticals, The Clock Is…

Amazon (NSDQ:AMZN) US$200B AI Capex Bill, and Why AWS Still Wins

April 10, 2026

Amazon AI trade comes back,…

Amazon Is Making Returns from AI – A Whopping US$15bn In Just One Quarter!

April 10, 2026

It is that time of…

These 4 ASX Stocks Benefit From the NDIS, But Stand To Lose If the Scheme is Curtailed!

April 10, 2026

A handful of ASX Stocks…

CrowdStrike (NDQ:CRWD): The Cyber Defender the AI Era Cannot Do Without

April 10, 2026

CrowdStrike (NDQ:CRWD) has evolved well…

Oil Crashed 15% on Iran Ceasefire: Should You Buy, Sell or Hold Woodside (ASX:WDS), Santos (ASX:STO) and Beach Energy (ASX:BPT)?

April 10, 2026

Thursday was a rough day…

Tamboran Resources (ASX:TBN) Drops 17% on US$198M Capital Raise- Dilution Pain or Buying Opportunity?

April 10, 2026

Tamboran falls on a major…

Is Bendigo Bank (ASX:BEN) a Buy After Strong Q3 Results and Its Bold Outsourcing Bet?

April 10, 2026

Bendigo Bank jumps on Q3…

Alkane Resources (ASX:ALK) Rises 4% on Strong March Quarter: Is This Gold Stock Worth Buying Now?

April 10, 2026

Alkane Resources rises on strong…

Regis Resources (ASX:RRL) Has A$1.1 Billion in Cash and a Court Ruling Due- Is It Finally Time to Buy?

April 9, 2026

Regis Resources (ASX:RRL) quietly delivered…

From Near-Disaster to Record A$158m Cash Flow: Is Bellevue Gold (ASX:BGL) Now a Serious Buy?

April 9, 2026

Bellevue Gold surges on record…

Pro Medicus (ASX:PME) Rallies on $23m Maryland Contract. Is This the Dip Investors Should Be Buying?

April 9, 2026

Pro Medicus jumps on new…

Xamble Group (ASX:XGL) 3x influencer network overnight, but $700k synergy target looks light

April 9, 2026

Xamble buys YouthsToday, adds nano…

The Iran US Ceasefire, What Happened & What It Means for Investors

April 9, 2026

Hormuz is still Iran’s weapon…

Find Us in

Stocks Down Under Analysts delve into a large variety of ASX-listed stocks and sectors.

Iron Ore Falls to $103 on China’s Near-Record Stockpiles- What It Means for ASX Mining Stocks

By Ujjwal Maheshwari | April 11, 2026

ASX Mining Stocks Under Pressure as Iron Ore Falls Iron ore has slipped to around US$103 per tonne on the Singapore Exchange, testing levels not seen in over a month, as Chinese ports hold near-record amounts of the steel-making ingredient- 177.5 million tonnes across 47 major facilities. For investors in BHP (ASX:BHP), Rio Tinto (ASX:RIO)…

Life360 (ASX: 360) Cuts Jobs for AI- Red Flag or the Best Reason to Buy This ASX Tech Stock Right Now?

By Ujjwal Maheshwari | April 11, 2026

Life360’s AI move could be a buying chance, not a warning Life360 (ASX: 360) shares fell 3.28% to A$19.48 on Friday after CEO Lauren Antonoff announced a workforce reduction to transition the company towards an “AI-native model”. The exact number of roles cut hasn’t been disclosed, but the market’s reaction was swift and negative. For…

AMA Group (ASX:AMA) recovery is now being tested by whether cash flow can sustain the turnaround

By Charlie Youlden | April 10, 2026

AMA Group (ASX: AMA)’s recovery story is now being tested by whether improving earnings can translate into durable cash flow across its collision repair network, rather than fading as a short-term rebound. The business has moved beyond a pure survival narrative, but operating risks in parts of the network and still-soft repair volumes mean the…

Radiopharm Theranostics (ASX: RAD) is increasingly defined by whether RAD101 can justify a registrational pathway

By Charlie Youlden | April 10, 2026

Radiopharm Theranostics (ASX:RAD) is increasingly defined by whether its lead imaging asset RAD101 can convert encouraging mid-stage data into a credible registrational pathway, against a backdrop where clinical and execution risk remains high. The company has assembled a broad oncology radiopharmaceutical pipeline, but its near-term valuation still centres on whether one program can move from…

3P Learning (ASX:3PL) must arrest school churn to protect its valuation

By Charlie Youlden | April 10, 2026

3P Learning (ASX: 3PL)’s valuation now hinges on whether the business review can arrest B2B school churn and declining revenue before the longer-term value in Reading Eggs, Mathletics and its expanding US homeschool channel is eroded. The urgency is clear from the half-year result: revenue fell to $51.9m and underlying EBITDAA to $5.7m, prompting management…

IperionX (ASX: IPX) needs repeat Virginia orders to unlock its titanium platform value

By Charlie Youlden | April 10, 2026

IperionX (ASX: IPX) is now a trade-off between the cash-hungry ramp-up at its Virginia Titanium Manufacturing Campus and the longer-term value of a government-backed domestic titanium platform that already has funding, feedstock and a permitted upstream asset in Titan. With Virginia online at 200tpa and expanding toward 1,400tpa, the company has moved beyond technology claims…

Telix Pharmaceuticals (ASX:TLX) Big Upside, but Only if the FDA Says Yes.

By Charlie Youlden | April 10, 2026

Telix Pharmaceuticals, The Clock Is Now Running For many investors following Telix Pharmaceuticals (ASX:TLX), the story has been the sharp fall in the share price after the FDA setback, with the stock dropping almost 70% from its high to its low. What is becoming clearer now is that the company is taking real steps toward…

Amazon (NSDQ:AMZN) US$200B AI Capex Bill, and Why AWS Still Wins

By Charlie Youlden | April 10, 2026

Amazon AI trade comes back, is it time to buy some stock Amazon is continuing to see strong growth through AWS, which is helping offset concerns around the scale of its capex buildout. In our view, that matters because over the long term Amazon still looks attractive, especially with AWS backlog expected to move toward…

Amazon Is Making Returns from AI – A Whopping US$15bn In Just One Quarter!

By Nick Sundich | April 10, 2026

It is that time of year again when Amazon releases its annual shareholder letter (along with the 1997 letter all over again) and the bottom line was that Amazon is making returns from AI – real returns, $15bn in a quarter to be exact! In our view, that number reframes both Amazon’s trajectory and the…

These 4 ASX Stocks Benefit From the NDIS, But Stand To Lose If the Scheme is Curtailed!

By Nick Sundich | April 10, 2026

A handful of ASX Stocks Benefit From the NDIS, but could lose if a long-cried for crackdown actually happens. We’re not saying they’ll go out of business, but the gravy train might slow down. What are the Best ASX Stocks to invest in? Check our buy/sell tips The explosion of the NDIS What began as…

Sector Analysis

The-Best-Mining-Stocks

The Best Mining Stocks

Mining and resources stocks have substantial potential given demand for all types of resources and metals from gold and iron ore to battery metals like lithium and graphite! There are over 700 stocks in this sector from big miners to small cap explorers.

The-Best-Tech-Stocks

The Best Tech Stocks

Tech stocks are appetising in the context of an increasingly digital world ranging from data centre builders, cloud services providers and cybersecurity companies. Many of the ASX's best performing stocks in the last decade have been tech stocks.

The-Best-Uranium-Stocks

The Best Uranium Stocks

Uranium stocks are in a good spot right now with rising demand for clean energy, nuclear energy making a comeback and yellowcake pricing reaching levels not seen since the GFC. This has enabled many companies with mothballed projects to bring them out of hibernation.

Untitled design

The Best Healthcare Stocks

There are dozens of Healthcare stocks on the ASX ranging from big names like CSL and Cochlear with established products and markets, to small cap biotechs and medtechs hoping to follow in their footsteps and commercialise the next big innovation.

The-Best-Mining-Stocks

The Best Mining Stocks

The-Best-Tech-Stocks

The Best Tech Stocks

The-Best-Uranium-Stocks

The Best Uranium Stocks

Share Type Analysis

The Best ASX Stocks Right Now

The Best ASX Stocks Right Now

The quest for the best stocks to buy now is a never-ending one, but armed with a solid investment strategy, you can create a diversified portfolio that stands the test of time. We provide our Top 10 ASX stocks we think investors should consider right now. 

The Best ASX Stocks Right Now

The Best ASX Stocks Right Now

The Top Penny Stocks

The Top Penny Stocks

Navigating ASX Penny stocks, can be complex, given the diversity of companies operating in various sectors and the high risk associated with them. But there is potential for impressive returns if investors can find the right company.

The Top Penny Stocks

The Top Penny Stocks

The Top Dividend Stocks

The Top Dividend Stocks

Investing in Dividend stocks can provide an additional source of income, and so are popular with a wide variety of investors. But only some companies pay dividends, and even consistent payers can fluctuate payouts year to year. We outline the Top Dividend Stocks for investors to consider.

The Top Dividend Stocks

The Top Dividend Stocks

size set 1

Top ASX Index Funds

Explore our comprehensive analysis of the top ASX index funds, carefully curated by industry experts. Discover which funds are currently outperforming and why, based on detailed market trends and performance metrics. Ideal for both new and seasoned investors seeking strategic investment opportunities on the ASX. Dive into our report today to make informed investment decisions.

size set 1

Top ASX Index Funds

size 2

The Top Blue Chip Stocks

Discover the best ASX blue chip stocks for investment. Our industry experts provide in-depth analysis on these well-established companies with strong credit ratings and a long history of performance and stability. Explore market leaders like Commonwealth Bank of Australia, BHP Group Ltd, and National Australia Bank Limited.

size 2

The Top Blue Chip Stocks

size 3

Top ASX Growth Stocks for Investing

Explore our comprehensive analysis of the top ASX growth stocks for investing. Our industry experts have curated a detailed report on the most promising opportunities available in the market. Whether you're a seasoned investor or just starting out, our insights provide valuable information to help you make informed decisions.

size 3

Top ASX Growth Stocks for Investing

Webinars and Interviews

Archer Materials presented at the Pitt Street Research Semiconductor Conference 2026

Archer Materials (ASX:AXE) Archer Materials‘ CEO Simon Ruffell presented at the 2026 edition of the Pitt…

Nanoveu presented at the Pitt Street Research Semiconductor Conference 2026

Nanoveu (ASX:NVU) Nanoveu’s EMASS founder Mohamed Sabry presented at the 2026 edition of the Pitt Street…

Weebit Nano presented at the Pitt Street Research Semiconductor Conference 2026

Weebit Nano (ASX:WBT) Weebit Nano‘s CEO Coby Hanoch presented at the 2026 edition of the Pitt…

BluGlass presented at the Pitt Street Research Semiconductor Conference 2026

BluGlass (ASX:BLG) BluGlass‘ CEO Jim Haden presented at the 2026 edition of the Pitt Street Research…

Investment Glossary

What Is a Small Cap Company? A Complete Guide for Investors

September 24, 2024

Overview of Small Cap Companies…

What is the All Ordinaries Index and How Does It Work?

September 20, 2024

The All Ordinaries Index, also…

What is Commodity? Understanding Commodity Trading

May 23, 2024

Introduction to Commodities Commodities are…

Overview of Securities in the Australian Financial Market

May 23, 2024

What is a security? Security refers…

What Is an IPO? Understanding Initial Public Offerings

May 23, 2024

What is IPO? An Initial Public…

The Team Behind Stocks Down Under

1rw

Stuart Roberts

Co-Founder

Stuart Roberts is the co-founder of Stocks Down Under. Previously, Stuart covered the healthcare and biotechnology sectors at NDF Research and at stockbroking firms Southern Cross Equities, Bell Potter and Baillieu Holst from 2002 to 2015, where he developed a reputation for detailed analysis on previously uncovered Life Science companies. In 2018, he co-founded Pitt Street Research

Marc-circle-300x300_webp

Marc Kennis

Co-Founder

Marc is the co-founder of Stocks Down Under and has 25+ years experience analyzing companies in a range of sectors, including Food & Beverage, Industrials, Technology, Medical Equipment, Telecom and Media. Prior to moving to Australia in 2014, he worked for a number of brokers and banks in The Netherlands, including ING and Rabobank. In 2018, Marc co-founded Pitt Street Research,

The Team Behind Stocks Down Under

STUART ROBERTS

Stuart Roberts is the co-founder of Stocks Down Under. Previously, Stuart covered the healthcare and biotechnology sectors at NDF Research and at stockbroking firms Southern Cross Equities, Bell Potter and Baillieu Holst from 2002 to 2015, where he developed a reputation for detailed analysis on previously uncovered Life Science companies. In 2018, he co-founded Pitt Street Research together with Marc.

MARC KENNIS

Marc is the co-founder of Stocks Down Under and has 20+ years experience analyzing companies in a range of sectors, including Food & Beverage, Industrials, Technology, Medical Equipment, Telecom and Media. Prior to moving to Australia in 2014, he worked for a number of brokers and banks in The Netherlands, including ING and Rabobank. In 2018, Marc co-founded Pitt Street Research, Australia's preeminent issuer-sponsored equities research firm.

PETER KILBY

Pete is Stocks Down Under's head of customer service. He is an avid investor with a knack for deep-dive company research. Pete likes the more established companies on ASX, but doesn't shy away from the occasional risky play. At Stocks Down Under he gets to do the two things he loves most, investing and talking to like-minded people.

Please enter your name.
Please enter a message.